SOW
CSTL icon

State of Wyoming’s Castle Biosciences CSTL Stock Holding History

State of Wyoming’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Sell
4,923
-4,599
-48% -$102K 0.01% 1325
2026
Q1 		$234K Buy
9,522
+6,508
+216% +$213K 0.03% 842
2025
Q4 		$117K Buy
+3,014
New +$97.2K 0.01% 1264
2024
Q1 		– Sell
-930
Closed -$20.1K – 1651
2023
Q4 		$20.1K Buy
930
+116
+14% +$2.04K ﹤0.01% 1543
2023
Q3 		$13.7K Buy
814
+288
+55% +$5.04K ﹤0.01% 1523
2023
Q2 		$7.22K Buy
526
+129
+32% +$2.61K ﹤0.01% 1484
2023
Q1 		$9.02K Buy
397
+11
+3% +$269 ﹤0.01% 1500
2022
Q4 		$9.09K Sell
386
-2
-0.5% -$46 ﹤0.01% 1467
2022
Q3 		$10K Sell
388
-15
-4% -$421 ﹤0.01% 1426
2022
Q2 		$9K Sell
403
-369
-48% -$8.57K 0.01% 1650
2022
Q1 		$35K Buy
772
+206
+36% +$8.51K 0.02% 1238
2021
Q4 		$24K Sell
566
-18
-3% -$941 0.01% 1421
2021
Q3 		$39K Buy
584
+242
+71% +$17K 0.03% 829
2021
Q2 		$25K Buy
+342
New +$22.6K 0.02% 885

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

State of Wyoming's CSTL Position: Q2 2026 in Review

State of Wyoming reduced its Castle Biosciences (CSTL) stake by 48% in Q2 2026, selling an estimated $102K and leaving 4,923 shares worth $117K. The position accounts for 0.01% of the portfolio, ranked #1325.

State of Wyoming first reported a position in CSTL in Q2 2021 and has held it in 14 quarters since. The position peaked at $234K in Q1 2026. 61 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • State of Wyoming held 4,923 shares of Castle Biosciences worth $117K as of Q2 2026.
  • State of Wyoming sold 4,599 Castle Biosciences shares in Q2 2026, an estimated $102K.
  • Castle Biosciences made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1325 holding.
  • State of Wyoming first reported a position in Castle Biosciences in Q2 2021 and has held it in 14 quarters since.
  • State of Wyoming's Castle Biosciences position peaked at $234K in Q1 2026.
  • 61 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.